Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar R1000 (21.78) Submitted: 1/10/2012 3:48:09 PM : Outperform Start Price: $74.03 REGN Score: +76.25

Ahead of it's competitors in a drug Macular Degeneration which causes blindness in 50+ age group.

Featured Broker Partners


Advertisement